GENB - CIK 0002100782
Generate Biomedicines, Inc. trades as GENB and has a market capitalization of $1.69 B, making it the #2229 largest US-listed company by market value. This page tracks Generate Biomedicines, Inc. through 47 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| New insider ownership | 3 | 2026-03-12 |
| Insider trade | 4 | 2026-03-06 |
| Insider trade | 4 | 2026-03-02 |
| Insider trade | 4 | 2026-03-02 |
The largest companies sharing Generate Biomedicines, Inc.'s SEC industry classification (pharmaceutical preparations).
Generate Biomedicines, Inc. (GENB) has a market capitalization of $1.69 B as of 2026-06-11, ranking #2229 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.